GL1X · GenesisL1 explorer

Research workbench

Crystal structure at 1.9 ångströms resolution of human immunodeficiency virus (HIV) II protease complexed with L- 735,524, an orally bioavailable inhibitor of the HIV proteases

Analyse Crystal structure at 1.9 ångströms resolution of human immunodeficiency virus… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1HSG
Type
protein
Length
198 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
HIV-1 protease
EC
3.4.23.-
UniProt
P03367
Ligands
MK1
Pockets
1 · best druggability 0.73

Structure

x-ray diffraction · 1 distinct chain · 4% helix, 56% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BHIV-1 protease (EC 3.4.23.-)protein994% helix, 56% strandP03367

Ligands and binding sites

  • MK1 · N-[2(R)-hydroxy-1(S)-indanyl]-5-[(2(S)-tertiary butylaminocarbonyl)-4(3-pyridylmethyl)piperazino]-4(S)-hydroxy-2(R)-phenylmethylpentanamide · ligand · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13860.730.8435MK1

Interfaces

1 interface between chains.

  • A–B · 1846 Ų buried · 37 hydrogen bonds · protein-protein

Compared structures

  • 1HSG · Crystal structure at 1.9 ångströms resolution of human immunodeficiency virus (HIV) II… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.